Photoactivatable Sequential Destruction of Multiorganelles for Cancer Therapy

Area of Science:

• Biomedical Engineering
• Photodynamic Therapy
• Cancer Research

Background:

• Organelle-targeted cancer therapy offers precision but is limited by single-organelle destruction.
• Current therapeutics often show limited efficacy due to targeting only one organelle.

Purpose of the Study:

• To develop a photoactivatable probe for sequential destruction of multiple organelles in cancer cells.
• To investigate the in vitro and in vivo efficacy of this novel therapeutic strategy.
• To enable real-time monitoring of organelle destruction via fluorescence color conversion.

Main Methods:

• Development of a photoactivatable probe for sequential organelle targeting.
• Evaluation of cancer cell eradication in vitro.
• Assessment of tumor growth suppression in vivo.
• Utilizing fluorescence imaging for in situ observation of sequential organelle destruction.

Main Results:

• The photoactivatable probe successfully eradicated cancer cells in vitro.
• The probe demonstrated efficacy in suppressing tumor growth in vivo.
• Sequential destruction of lysosomes, lipid droplets, and mitochondria was achieved.
• Green-to-red fluorescence conversion confirmed in situ organelle destruction.

Conclusions:

• The developed photoactivatable probe enables sequential destruction of multiple organelles in cancer cells.
• This multi-organelle targeting strategy significantly improves therapeutic efficacy.
• The fluorescence color conversion provides a visual indicator for monitoring treatment progress.
• This approach offers a novel and effective strategy for cancer treatment.